Chapter 1 Osimertinib Drugs Market Scope
1.1 Product Overview and Scope of Osimertinib Drugs
1.2 Objective of the study
1.3 List of Assumptions
1.4 Currency Exchange Rate
1.5 Global Osimertinib Drugs Segment by Type
1.6 Global Osimertinib Drugs Segment by Application
1.7 Global Osimertinib Drugs Market Size Estimates and Forecasts
1.7.1 Global Osimertinib Drugs Market Sales (No. of Tablets) Estimates and Forecasts
1.7.2 Global Osimertinib Drugs Market Revenue (US$ Mn) Estimates and Forecasts
1.7.3 Osimertinib Drugs Market Size (US$ Mn) by Region: 2016 Versus 2021 Versus 2027
Chapter 2 Global Osimertinib Drugs Market Dynamics and Overview
2.1 Market Dynamics
2.1.1 Drivers
2.1.1.1 Tagrisso an effective alternative for the treatment of NSCLC with mutation
2.1.1.2 Surging demand for effective medication for the management of Lung cancer
2.1.2 Restraints
2.1.2.1 Availability of Counterfeit products in the market
2.1.3 Opportunity
2.1.3.1 Increasing R&D investments
2.1.4 Trend
2.1.4.1 Strategic alliances and government approvals are Emerging as the Significant Marketing Strategy
2.2 COVID-19 Impact
2.2.1 Global COVID-19 Status Overview
2.3 PORTER FIVE FORCES
Chapter 3 Global Osimertinib Drugs Market Analysis, by Region
3.1 Sector Breakdown Assessment, 2016-2027
3.1.1 Global Osimertinib Drugs Revenue (US$ Million) by Region (2016-2027)
Chapter 4 Global Osimertinib Drugs Market Analysis, by Type
4.1 Introduction
Chapter 5 Global Osimertinib Drugs Market Analysis, by Application
5.1 Introduction
Chapter 6 North America Osimertinib Drugs Market Analysis
6.1 Introduction
6.2 North America Osimertinib Drugs Market, by Country
Chapter 7 Asia Pacific Osimertinib Drugs Market Analysis
7.1 Introduction
7.2 Asia Pacific Osimertinib Drugs Market, by Country
Chapter 8 Europe Osimertinib Drugs Market Analysis
8.1 Introduction
8.2 Europe Osimertinib Drugs Market, by Country
Chapter 9 South America Osimertinib Drugs Market Analysis
9.1 Introduction
9.2 South America Osimertinib Drugs Market, by Country
Chapter 10 MEA Osimertinib Drugs Market Analysis
10.1 Introduction
10.2 MEA Osimertinib Drugs Market, by Country
Chapter 11 Company Profiles
11.1 AstraZeneca
11.1.1 Company Information
11.1.2 Main Business Overview
11.1.3 Manufacturing Sites and Geographical presence
11.1.4 Products Offered
11.1.5 Recent Development
11.1.6 Company Financials
Chapter 12 OSIMERTINIB DRUGS MANUFACTURING COST ANALYSIS
12.1 Osimertinib Drugs Industrial Chain Analysis
12.2 Osimertinib Drugs Key Raw Materials Analysis
12.2.1 Key Raw Materials
12.2.2 Key Suppliers of Raw Materials
12.3 Manufacturing Process Analysis of Osimertinib Drugs
Chapter 13 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
13.1 Marketing Channel
13.2 Osimertinib Drugs Distributors List
13.3 Osimertinib Drugs Customers:
Chapter 14 Research Methodology
14.1 Research Process
14.2 Market Size Estimation Methodology
14.2.1 Primary Research
14.2.2 Secondary Research
14.2.2.1 Secondary Research Sources
14.2.3 Analyst Tools and Models
14.3 Forecasting Methodology